WMJ Vol 120: Evaluating the Impact of Provider Type and Patient Diagnosis on Patient No-Shows to Vascular Clinic
Background: No-shows are a source of burden that lead to wasted resources. While prior research has established that many patient-level affect impact no-show rates, the impact of referring provider-level factors, in particular the type of referring provider—and specific diagnosis are still largely unknown.
Materials and Methods: Retrospective chart review examining new patient consults scheduled for outpatient vascular surgery clinic from August 1, 2014 through February 28, 2015 was conducted. The specialty types of the referring physicians and the reason for referral (patient diagnosis) were recorded.
Results: Of 227 new patient consults scheduled, 30% were no-shows to their appointment. No-show rates were significantly higher when the patient was referred by a primary care physician versus a specialist and differed significantly based on patient diagnosis.
Conclusions: Given that referring provider type and patient diagnosis significantly affect no-show rates, interventions that integrate the community of providers are needed to reduce no-shows.
The target audience for this journal-based activity is healthcare providers caring for the people and communities of Wisconsin and beyond.
The patient no-show rate is one of the most significant factors impeding both the effectiveness and efficiency of health care delivery services for the health care team.
After reading this article, learners should be able to:
- Define the impact of provider type and patient diagnosis on the rates of patient no-shows to the vascular clinic.
- Distinguish provider type and patient diagnosis in the larger schema of factors that affect patient no-show rates.
- Explain the potential reasons for the impact of provider type and patient diagnosis on no-show rates.
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors may disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below:
|Name of Individual||Individual's Role in Activity|
Name of Commercial Interest &
|Terese Bailey, BS||Accreditation Specialist||No relevant relationships with ineligible companies to disclose||No|
|Valerie Du, BA||Author||No relevant relationships with ineligible companies to disclose||No|
|David Dwyer, PhD, RN, NE-BC||Reviewer||No relevant relationships with ineligible companies to disclose||No|
|Rohit Gupta, BA||Author||No relevant relationships with ineligible companies to disclose||No|
|SreyRam Kuy, MD, MHS, FACS||Author||No relevant relationships with ineligible companies to disclose||No|
|Qiyan Mu, RN, PhD||Reviewer||No relevant relationships with ineligible companies to disclose||No|
|Jutta Novalija, MD, PhD||Reviewer||No relevant relationships with ineligible companies to disclose||No|
|Katherine Recka, MD||Reviewer||No relevant relationships with ineligible companies to disclose||No|
|Cayla Roy, BS||Author||No relevant relationships with ineligible companies to disclose||No|
|Robert Treat, PhD||Editor||No relevant relationships with ineligible companies to disclose||No|
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be commercial interests.
|In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Wisconsin Medical Journal. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™
Free, current version of Chrome, Firefox, Safari, or Edge. Some older browsers and Microsoft Internet Explorer could produce error messages or not display the content correctly.
Free, current version of Adobe Acrobat Reader or other .pdf reader.